Assignee
AARDVARK THERAPEUTICS INC
US·6 granted patents·10 pending applications·0 citations·filing 2019–2025
Top patents by PatentIndex Score
16 records- 0188US12318364B2Isoflavonoid compositions and methods for the treatment of cancerAARDVARK THERAPEUTICS INC·Filed 2023·Granted Jun 3, 2025·0 cites·17 claims
- 0286US12329739B2Isoflavonoid compounds and methods for the treatment of cancerAARDVARK THERAPEUTICS INC·Filed 2023·Granted Jun 17, 2025·0 cites·18 claims
- 0367US2025049924A1Abuse-Deterrent Pharmaceutical Composition with Aversion PropertiesAARDVARK THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0462US12427125B2Method for treating SARS and treating or preventing ARDSAARDVARK THERAPEUTICS INC·Filed 2021·Granted Sep 30, 2025·0 cites·14 claims
- 0562US2024366505A1Liquid Resin Extended-Release Oral Naltrexone Formulation for Treating Autism-Related DisordersAARDVARK THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0661US12414934B2Combination therapiesAARDVARK THERAPEUTICS INC·Filed 2021·Granted Sep 16, 2025·0 cites·13 claims
- 0756US12268660B2Oral pharmaceutical formulations of bitter compounds for pulmonary hypertensionAARDVARK THERAPEUTICS INC·Filed 2019·Granted Apr 8, 2025·0 cites·9 claims
- 0855US2024390306A1Monohydrate Salt of Denatonium AcetateAARDVARK THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0951US2022280457A1Oral pharmaceutical immediate release composition and method of treatment for weight lossAARDVARK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1050US2024216476A1Combination of bitter receptor agonist and gut-signaling compoundAARDVARK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1149US2023121611A1Monohydrate Salt of Denatonium AcetateAARDVARK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1249US2023096528A1Pharmaceutical Composition for Treatment or Prevention of Multiple Inflammatory disordersAARDVARK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1348US2024100001A1Denatonium salt for use in preventing, preventing progression and treating fatty liver diseasesAARDVARK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1446US2025352498A1Pharmaceutical formulations containing phenylbutyrate and methods thereofAARDVARK THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1545US12201593B2Oral pharmaceutical formulations of bitter compounds for asthmaAARDVARK THERAPEUTICS INC·Filed 2019·Granted Jan 21, 2025·0 cites·12 claims
- 1643US2022193013A1Pharmaceutical Composition for Treatment or Prevention of Multiple Inflammatory DisordersAARDVARK THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AARDVARK THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →